Faculty profile

Humberto Jijon

ResearcherMedicineUniversity of Calgary

This profile is built from public research funding records (CIHR, NSERC and SSHRC) and PubMed. We have not imported them from a University of Calgary directory, so their courses may be missing. Find their university profile.

Humberto Jijon

Researcher

Medicine

Health Sciences

University of Calgary

Calgary, Alberta, Canada

Supervision signals

Has led research grants, which requires an independent research appointment. Ask their department whether they supervise graduate students.
8 publications in the last five years, latest in 2026.
Senior (last) author on 1 recent paper, a sign of leading a research group.
Principal investigator on 1 research grant (1 CIHR), most recently in 2018.

These signals come from public records, including CIHR, NSERC and SSHRC funding decisions. Ask the professor or the graduate program whether they are taking new students.

Academic metrics

Publications

Citations

h-index

Collaborators

Grants

Publications by year

Counts cover the works listed on the university profile; citation counts come from Dimensions.

Profiles and links

Search on Google Scholar

Find them onX · LinkedIn · Bluesky · YouTube

Signals and details

Research

Cellular Biology Crohn'S Disease Inflammation Inflammatory Bowel Disease Intestinal Fibrosis Meta-Transcriptomics Proteomics Rna-Sequencing

Latest papers

Significant Increase in Clostridioides difficile Mortality During the COVID-19 Pandemic: A Nationwide Study.
Gastro hep advances · 2026
Preliminary Results From a Multicenter, Randomized Trial Using Fecal Microbiota Transplantation to Induce Remission in Patients With Mild-to-Moderate Crohn's Disease
American Journal of Gastroenterology · 2025
Patient preferences for active ulcerative colitis treatments and fecal microbiota transplantation
Therapeutic Advances in Chronic Disease · 2024

All 20 publications

Latest funding

Reducing Morbidity and Mortality in Inflammatory Bowel Disease by Targeting Intestinal Fibrosis
CIHR · 2018 · Principal investigator
$20,000
Fecal microbial transplantation in the management of patients with mild-to-moderate Crohn's disease
CIHR · 2016 · Co-investigator
$638,356

All 2 grants and awards

20 publications.

Significant Increase in Clostridioides difficile Mortality During the COVID-19 Pandemic: A Nationwide Study.

Besney J, Ray CM, Buhler KA, Krawchuk S, Jijon H, Lu C, Seow CH, Novak KL, St-Pierre J, Singh S, Panaccione R, Kaplan GG, Ma C

Gastro hep advances2026

DOI: 10.1016/j.gastha.2026.100942 PMID: 42094683

Preliminary Results From a Multicenter, Randomized Trial Using Fecal Microbiota Transplantation to Induce Remission in Patients With Mild-to-Moderate Crohn's Disease

Kao D, Wong K, Jijon H, Moayyedi P, Franz R, McDougall C, Hotte N, Panaccione R, Semlacher E, Kroeker KI

American Journal of Gastroenterology202528 citations

DOI: 10.14309/ajg.0000000000003196

Patient preferences for active ulcerative colitis treatments and fecal microbiota transplantation

Marshall DA, MacDonald KV, Kao D, Bernstein CN, Kaplan GG, Jijon H, Hazlewood G, Panaccione R, Nasser Y, Raman M

Therapeutic Advances in Chronic Disease20247 citations

DOI: 10.1177/20406223241239168

Epidemiologic Burden and Projections for Eosinophilic Esophagitis-Associated Emergency Department Visits in the United States: 2009-2030.

Lam AY, Lee JK, Coward S, Kaplan GG, Dellon ES, Bredenoord AJ, Jairath V, Crowley E, Gupta M, Jijon H, Nasser Y, Andrews CN, Chehade M, Gonsalves N, Hirano I, Ma C

Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association2023

DOI: 10.1016/j.cgh.2023.04.028 PMID: 37164113

Diffuse Jejunal Lipomatosis and Associated Complications.

Tkachuk B, Collins R, Stukalin I, Gupta M, Ng D, Jijon H

ACG case reports journal2023Senior author

DOI: 10.14309/crj.0000000000001179 PMID: 37860810

Tissue imaging reveals disruption of epithelial mitochondrial networks and loss of mitochondria-associated cytochrome-C in inflamed human and murine colon.

Chojnacki AK, Navaneetha Krishnan S, Jijon H, Shutt TE, Colarusso P, McKay DM

Mitochondrion2023

DOI: 10.1016/j.mito.2022.10.004 PMID: 36356719

Evaluation of an integrated yoga program in patients with inflammatory bowel disease: A pilot study.

Kaur S, D'Silva A, Rajagopalan V, Kumar A, Jijon H, Panaccione R, Fung T, Taylor LM, Raman M

Explore (New York, N.Y.)2022

DOI: 10.1016/j.explore.2021.04.006 PMID: 34210638

Crohn's disease therapeutic dietary intervention (CD-TDI): study protocol for a randomised controlled trial.

Raman M, Ma C, Taylor LM, Dieleman LA, Gkoutos GV, Vallance JK, McCoy KD, Lewis I, Jijon H, McKay DM, Mutch DM, Barkema HW, Gibson D, Rauch M, Ghosh S

BMJ open gastroenterology2022

DOI: 10.1136/bmjgast-2021-000841 PMID: 35046093

Cathelicidin-mediated lipopolysaccharide signaling via intracellular TLR4 in colonic epithelial cells evokes CXCL8 production.

Holani R, Babbar A, Blyth GAD, Lopes F, Jijon H, McKay DM, Hollenberg MD, Cobo ER

Gut microbes2020

DOI: 10.1080/19490976.2020.1785802 PMID: 32658599

Elevated interferon-gamma levels during pregnancy are associated with adverse maternofetal outcomes in IBD.

Jijon H, Ueno A, Sharifi N, Leung Y, Ghosh S, Seow CH

Gut2020First author

DOI: 10.1136/gutjnl-2019-319656 PMID: 31722975

Something wrong or missing on this profile? Suggest a correction

Humberto Jijon

Research

Latest papers

Latest funding

Significant Increase in Clostridioides difficile Mortality During the COVID-19 Pandemic: A Nationwide Study.

Preliminary Results From a Multicenter, Randomized Trial Using Fecal Microbiota Transplantation to Induce Remission in Patients With Mild-to-Moderate Crohn's Disease

Patient preferences for active ulcerative colitis treatments and fecal microbiota transplantation

Epidemiologic Burden and Projections for Eosinophilic Esophagitis-Associated Emergency Department Visits in the United States: 2009-2030.

Diffuse Jejunal Lipomatosis and Associated Complications.

Tissue imaging reveals disruption of epithelial mitochondrial networks and loss of mitochondria-associated cytochrome-C in inflamed human and murine colon.

Evaluation of an integrated yoga program in patients with inflammatory bowel disease: A pilot study.

Crohn's disease therapeutic dietary intervention (CD-TDI): study protocol for a randomised controlled trial.

Cathelicidin-mediated lipopolysaccharide signaling via intracellular TLR4 in colonic epithelial cells evokes CXCL8 production.

Elevated interferon-gamma levels during pregnancy are associated with adverse maternofetal outcomes in IBD.

Reducing Morbidity and Mortality in Inflammatory Bowel Disease by Targeting Intestinal Fibrosis

Fecal microbial transplantation in the management of patients with mild-to-moderate Crohn's disease

Frequent collaborators

Remo Panaccione

Christopher Ma

Yasmin Nasser

Cathy Lu

Dina Kao

Paul Moayyedi

Vipul Jairath

Deanna Gibson

Farhad Peerani

Paul Beck

David Proud

Simon Hirota

Glen Hazlewood

Ian Lewis

Neeraj Narula